F_mbjzUCnrjkXsrs461D32YJD9CGWQoWwptvxTREeMo Neuromuscular Blocker - NIMBEX® (cisatracurium besylate)

NIMBEX® (cisatracurium besylate)

grdientline
A Nondepolarizing Neuromuscular Blocking (NMB) Agent
nimbex-200-mob
nimbex-20-mob
nimbex-10-mob

An appropriate choice for your patients requiring an NMB1

     

  • Intermediate onset and duration of action
  • Severe anaphylactic reactions to NMBs, including NIMBEX, have been reported
  • Administer in carefully adjusted dosage by experienced clinicians in facilities with resuscitation/life support capabilities
  • Clinical trial adverse events (AEs) were uncommon in surgical patients (N=945): No events reported >1%
  • AEs <1%: bradycardia, hypotension, flushing, bronchospasm, and/or rash
  •